TEM

Tempus AI, Inc. NASDAQ

Healthcare ·Medical - Healthcare Information Services ·US · tempus.com

$55.81

Mkt Cap $9.7B

52w Low $41.73 22.5% of range 52w High $104.32

50d MA $50.80 200d MA $67.16

P/E (TTM) -39.0x

EV/EBITDA -47.2x

P/B 19.5x

Debt/Equity 1.7x

ROE -49.9%

P/FCF -43.0x

RSI (14) —

ATR (14) —

Beta 4.90

50d MA $50.80

200d MA $67.16

Avg Volume 5.4M

About

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of l…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 24, 2026	AMC	-0.04	-0.04	+8.7%	57.95	-1.5%	-7.3%	-4.4%	-8.1%	-8.0%	-11.3%	-21.4%	—
Nov 4, 2025	AMC	-0.17	-0.11	+36.2%	84.49	-2.7%	-2.6%	-14.7%	-15.3%	-15.0%	-15.3%	-9.7%	—
Aug 8, 2025	AMC	-0.23	-0.22	+4.3%	60.87	-1.4%	-0.1%	+9.0%	+14.4%	+17.6%	+21.2%	+31.8%	—
May 6, 2025	AMC	-0.26	-0.24	+7.7%	52.19	-0.1%	+12.6%	+25.0%	+17.6%	+20.1%	+32.0%	+12.4%	—
Feb 24, 2025	AMC	-0.15	-0.18	-20.0%	69.57	-15.9%	-15.0%	-10.5%	-20.5%	-19.2%	-26.8%	-23.5%	—
Nov 4, 2024	AMC	-0.27	-0.25	+6.1%	49.50	-1.4%	-10.1%	+15.1%	+14.7%	+49.0%	+56.8%	+17.2%	—
Aug 6, 2024	AMC	-0.59	-0.63	-6.8%	40.65	-1.8%	-4.5%	-4.2%	-4.7%	-4.8%	+4.9%	+36.9%	—
Jun 17, 2024	AMC	—	-0.38	—	36.48	+1.4%	-16.9%	-25.3%	-21.5%	-30.6%	-31.6%	+9.2%	—
Dec 31, 2023	AMC	—	-0.30	—	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	—	-0.31	—	—	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-0.33	—	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-0.32	—	—	—	—	—	—	—	—	—	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 30	Guggenheim	Maintains	Buy → Buy	—	$42.62	$42.36	-0.6%	-0.6%	+6.1%	+10.3%	+11.2%	+11.0%
Mar 11	Needham	Maintains	Buy → Buy	—	$50.90	$51.54	+1.3%	+3.5%	-2.7%	-1.8%	-0.0%	-0.1%
Mar 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$52.26	$50.89	-2.6%	+0.1%	-2.6%	+0.8%	-5.2%	-4.4%
Mar 3	Morgan Stanley	Maintains	Overweight → Overweight	—	$53.31	$51.13	-4.1%	-3.6%	-3.8%	-0.5%	-2.0%	-1.9%
Feb 25	Needham	Maintains	Buy → Buy	—	$57.95	$57.08	-1.5%	-7.3%	-4.4%	-8.1%	-8.0%	-11.3%
Feb 25	JP Morgan	Maintains	Neutral → Neutral	—	$57.95	$57.08	-1.5%	-7.3%	-4.4%	-8.1%	-8.0%	-11.3%
Feb 25	BTIG	Maintains	Buy → Buy	—	$57.95	$57.08	-1.5%	-7.3%	-4.4%	-8.1%	-8.0%	-11.3%
Dec 22	Canaccord Genuity	Maintains	Buy → Buy	—	$64.46	$66.36	+2.9%	+2.3%	+0.4%	-0.3%	-2.7%	-4.6%
Dec 15	JP Morgan	Maintains	Neutral → Neutral	—	$70.61	$70.53	-0.1%	-2.7%	-3.5%	-8.5%	-11.9%	-8.7%
Dec 2	Morgan Stanley	Maintains	Overweight → Overweight	—	$74.07	$74.60	+0.7%	-0.1%	+1.1%	+3.1%	+3.5%	+4.0%
Nov 25	BTIG	Maintains	Buy → Buy	—	$76.06	$76.01	-0.1%	+1.0%	+1.5%	+2.5%	-2.6%	-2.7%
Nov 11	Morgan Stanley	Maintains	Overweight → Overweight	—	$71.78	$71.60	-0.3%	-0.3%	-0.9%	-5.3%	-4.6%	-7.5%
Nov 11	Piper Sandler	Maintains	Neutral → Neutral	—	$71.78	$71.60	-0.3%	-0.3%	-0.9%	-5.3%	-4.6%	-7.5%
Nov 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$72.09	$71.35	-1.0%	-0.7%	-0.4%	-0.7%	-1.4%	-5.8%
Nov 5	Canaccord Genuity	Maintains	Buy → Buy	—	$84.49	$82.23	-2.7%	-2.6%	-14.7%	-15.3%	-15.0%	-15.3%
Nov 5	Needham	Maintains	Buy → Buy	—	$84.49	$82.23	-2.7%	-2.6%	-14.7%	-15.3%	-15.0%	-15.3%
Nov 5	BTIG	Maintains	Buy → Buy	—	$84.49	$82.23	-2.7%	-2.6%	-14.7%	-15.3%	-15.0%	-15.3%
Oct 22	Piper Sandler	Maintains	Neutral → Neutral	—	$89.10	$90.60	+1.7%	-4.3%	-2.3%	+0.1%	+2.8%	-2.8%
Oct 22	BTIG	Maintains	Buy → Buy	—	$89.10	$90.60	+1.7%	-4.3%	-2.3%	+0.1%	+2.8%	-2.8%
Sep 26	Guggenheim	Maintains	Buy → Buy	—	$77.33	$78.71	+1.8%	+1.5%	+1.6%	+4.4%	+13.8%	+15.5%
Sep 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$88.78	$89.26	+0.5%	-2.7%	-4.1%	-2.0%	-2.6%	-1.9%
Aug 20	BTIG	Maintains	Buy → Buy	—	$73.08	$70.77	-3.2%	+0.3%	+5.0%	+10.2%	+3.9%	+4.4%
Aug 12	Morgan Stanley	Maintains	Overweight → Overweight	—	$60.82	$61.35	+0.9%	+9.1%	+14.5%	+17.7%	+21.3%	+29.0%
Jul 29	BTIG	Maintains	Buy → Buy	—	$62.00	$61.05	-1.5%	-6.0%	-6.8%	-8.7%	-11.5%	-7.2%
Jun 30	Guggenheim	Maintains	Buy → Buy	—	$66.52	$65.69	-1.2%	-4.5%	-10.6%	-11.0%	-8.3%	-12.8%
Jun 25	BofA Securities	Maintains	Neutral → Neutral	—	$68.28	$69.58	+1.9%	-4.1%	+0.1%	-2.6%	-6.9%	-12.9%
May 15	Piper Sandler	Maintains	Neutral → Neutral	—	$64.78	$64.80	+0.0%	-3.4%	+1.1%	-1.6%	-3.6%	-10.3%
May 9	Morgan Stanley	Maintains	Overweight → Overweight	—	$65.22	$66.26	+1.6%	-5.9%	-3.9%	+5.7%	-0.7%	-4.0%
May 7	Needham	Maintains	Buy → Buy	—	$52.19	$52.13	-0.1%	+12.6%	+25.0%	+17.6%	+20.1%	+32.0%
Apr 24	Needham	Maintains	Buy → Buy	—	$49.55	$50.40	+1.7%	+8.0%	+6.8%	+8.5%	+9.6%	+4.3%
Apr 10	Needham	Maintains	Buy → Buy	—	$43.79	$42.85	-2.1%	-8.0%	-3.8%	-1.5%	-2.0%	-6.7%
Mar 6	Morgan Stanley	Maintains	Overweight → Overweight	—	$53.06	$50.47	-4.9%	-7.9%	-7.5%	-14.9%	-14.1%	-14.2%
Mar 4	Piper Sandler	Maintains	Neutral → Neutral	—	$50.93	$48.59	-4.6%	+3.5%	+4.2%	-4.1%	-3.6%	-11.3%
Mar 3	BofA Securities	Maintains	Neutral → Neutral	—	$56.18	$57.55	+2.4%	-9.3%	-6.1%	-5.6%	-13.0%	-12.6%
Feb 25	JP Morgan	Downgrade	Overweight → Neutral	—	$69.57	$58.49	-15.9%	-15.0%	-10.5%	-20.5%	-19.2%	-26.8%
Feb 25	Needham	Maintains	Buy → Buy	—	$69.57	$58.49	-15.9%	-15.0%	-10.5%	-20.5%	-19.2%	-26.8%
Feb 25	Guggenheim	Maintains	Buy → Buy	—	$69.57	$58.49	-15.9%	-15.0%	-10.5%	-20.5%	-19.2%	-26.8%
Feb 12	William Blair	Downgrade	Outperform → Market Perform	—	$71.21	$68.43	-3.9%	+3.7%	+17.6%	+25.6%	+15.1%	+20.4%
Jan 14	Needham	Maintains	Buy → Buy	—	$32.34	$33.10	+2.4%	-1.6%	+8.0%	+7.5%	+8.7%	+47.3%
Jan 14	Loop Capital	Maintains	Buy → Buy	—	$32.34	$33.10	+2.4%	-1.6%	+8.0%	+7.5%	+8.7%	+47.3%
Dec 13	BofA Securities	Maintains	Neutral → Neutral	—	$41.99	$42.00	+0.0%	-2.4%	-5.0%	-7.2%	-18.3%	-21.3%
Nov 12	Piper Sandler	Maintains	Neutral → Neutral	—	$77.62	$76.20	-1.8%	-12.3%	-12.3%	-27.0%	-32.5%	-30.4%
Nov 11	Stifel	Downgrade	Buy → Hold	—	$73.77	$69.78	-5.4%	+5.2%	-7.8%	-7.7%	-23.2%	-29.0%
Oct 15	Loop Capital	Maintains	Buy → Buy	—	$50.72	$50.72	+0.0%	-8.1%	-3.3%	-5.3%	-2.7%	-4.0%
Oct 2	BofA Securities	Downgrade	Buy → Neutral	—	$53.07	$52.50	-1.1%	-3.4%	-7.7%	-0.2%	-4.7%	-9.4%
Aug 7	Needham	Maintains	Buy → Buy	—	$40.65	$39.91	-1.8%	-4.5%	-4.2%	-4.7%	-4.8%	+4.9%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$40.65	$39.91	-1.8%	-4.5%	-4.2%	-4.7%	-4.8%	+4.9%

Recent Filings

8-K · 7.01 ! Medium

Tempus AI, Inc. -- 8-K 7.01: Regulation FD Disclosure

Tempus AI disclosed supplemental 2025 financial information and a management letter via its investor relations website, providing additional transparency into fourth-quarter and full-year performance.

Feb 24

Data updated apr 27, 2026 4:26am · Source: massive.com